Clinical Trials Browser

NIH × Topotecan × Tumor-Agnostic × Clear all

NCT00117013 2017-07-02

A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a

Phase 1 Completed

Neoplasm Metastasis, Neoplasms

NCT00006199 2005-06-24

Study of the Farnesyl Transferase Inhibitor, R115777, in Combination With Topotecan (NYU 99-32)

Phase 1 Unknown

Neoplasms